Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Regeneron Phase 3 Fianlimab Combination Misses Primary PFS Endpoint in First-Line Metastatic Melanoma
Regeneron's Phase 3 fianlimab-cemiplimab trial misses PFS significance vs. pembrolizumab, prompting manufacturing and pipeline reassessment.
Pharma Now Editorial Team
FDA Warns Against Use of Expired Amazon Basic Care Levonorgestrel 1.5 mg Across Multiple Lots
FDA flags multiple Amazon Basic Care levonorgestrel 1.5 mg lots delivered past expiration, raising distributor oversight and expiry control concerns.
Pharma Now Editorial Team
GSK Secures Updated FDA Approval Letter for TWINRIX Combination Hepatitis Vaccine in May 2026
FDA issues a May 2026 approval letter for GSK's TWINRIX, continuing a documented post-approval supplement cycle for the combination hepatitis vaccine.
Pharma Now Editorial Team
GlaxoSmithKline Biologicals Gains FDA Approval Action on BOOSTRIX in May 2026
FDA issued a May 14, 2026 approval letter for GSK Biologicals' BOOSTRIX Tdap vaccine, continuing a multi-year supplemental BLA activity pattern.
Pharma Now Editorial Team
